| Dr Karah Michelle Hanna, PHARMD | |
|
662 E Main St, Frankfort, KY 40601-2338 | |
| (502) 223-2827 | |
| Not Available |
| Full Name | Dr Karah Michelle Hanna |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 662 E Main St, Frankfort, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023689890 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 018101 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Karah Michelle Hanna, PHARMD 203 Hunters Ct, Versailles, KY 40383-1641 Ph: (812) 306-3501 | Dr Karah Michelle Hanna, PHARMD 662 E Main St, Frankfort, KY 40601-2338 Ph: (502) 223-2827 |
News Archive
CRISPR is one of the most exciting advances in gene-based medicine in decades. A uniquely powerful tool for editing the genome, it allows scientists to manipulate DNA with unprecedented precision by deleting unwanted or faulty genes and replacing them with different ones. Its promise in this field of medicine is immense, unlocking the potential for novel treatments across a wide range of therapeutic areas.
Politically, the biggest challenges facing the ACA are behind us. By my count, the law has already survived three near-death experiences: the Democrats' loss of a filibuster-proof Senate majority with the election of Scott Brown in Jan. 2010, the Supreme Court's June 2012 decision upholding (with one exception) the law's constitutionality, and President Obama's re-election last Nov. Much of what we see going on in Washington now is the death throes of the opposition, especially now that Americans are beginning to sign up for coverage (John McDonough, 10/9).
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, announced today that the Phase III, double-blind, placebo-controlled clinical trial for its leading drug candidate, KIT-302, successfully met the primary efficacy endpoint of the trial protocol as approved by the U.S. Food & Drug Administration (FDA).
A long noncoding RNA whose function was previously unknown turns out to play a vital role in mobilizing the immune response following a bone marrow transplant or solid organ transplantation.
A Cornell study provides important new insights into a common and deadly type of gastric cancer.
› Verified 7 days ago
Dr. Lisa Michele Hart, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 299 Kings Daughters Dr, Frankfort, KY 40601 Phone: 502-226-7518 | |
Michele Pinkston, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 275 E Main St, Frankfort, KY 40601 Phone: 502-227-2303 Fax: 502-227-2258 | |
Shawna Wallen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Brighton Park Blvd, Frankfort, KY 40601 Phone: 859-695-0918 | |
Mark Johnson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 709 E Main St, Frankfort, KY 40601 Phone: 502-226-7049 | |
Mr. Jackson M Bray, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 662 E Main St, Frankfort, KY 40601 Phone: 502-223-2827 Fax: 502-227-2026 | |
Cathy Ramsey Quarles, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 Clifty Dr, Frankfort, KY 40601 Phone: 502-330-4911 |